<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">109248</article-id>
<article-id pub-id-type="doi">10.7554/eLife.109248</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.109248.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
</article-categories><title-group>
<article-title>Maternal SETDB1 enables development beyond cleavage stages by extinguishing the MERVL-driven 2-cell totipotency transcriptional program in the mouse embryo</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8999-2952</contrib-id>
<name>
<surname>Zeng</surname>
<given-names>Tie-Bo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n2">#</xref>
<xref ref-type="author-notes" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fu</surname>
<given-names>Zhen</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Majewski</surname>
<given-names>Mary F</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liao</surname>
<given-names>Ji</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adams</surname>
<given-names>Marie</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9314-7009</contrib-id>
<name>
<surname>Szabó</surname>
<given-names>Piroska E</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>piroska.szabo@vai.org</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00wm07d60</institution-id><institution>Department of Epigenetics, Van Andel Institute</institution></institution-wrap>, <city>Grand Rapids</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00wm07d60</institution-id><institution>Bioinformatics and Biostatistics Core, Van Andel Institute</institution></institution-wrap>, <city>Grand Rapids</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label>Genomics Core, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/00wm07d60</institution-id><institution>Van Andel Institute</institution></institution-wrap>, <city>Grand Rapids</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Song</surname>
<given-names>Yan</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02v51f717</institution-id><institution>Peking University</institution>
</institution-wrap>
<city>Beijing</city>
<country country="CN">China</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Sussel</surname>
<given-names>Lori</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03wmf1y16</institution-id><institution>University of Colorado Anschutz Medical Campus</institution>
</institution-wrap>
<city>Aurora</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>*</label><p>Contributed equally.</p></fn>
<fn id="n2" fn-type="present-address"><label>#</label><p>Present address: University of Chicago, Chicago, Illinois, USA</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2026-01-28">
<day>28</day>
<month>01</month>
<year>2026</year>
</pub-date>
<volume>15</volume>
<elocation-id>RP109248</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-10-07">
<day>07</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-10-09">
<day>09</day>
<month>10</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.10.07.680892"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2026, Zeng et al</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Zeng et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-109248-v1.pdf"/>
<abstract><p>Loss of maternal SETDB1, a histone H3K9 methyltransferase, leads to developmental arrest prior to implantation, with very few mouse embryos advancing beyond the 8-cell stage, which is currently unexplained. We genetically investigate SETDB1’s role in the epigenetic control of the transition from totipotency to pluripotency—a process demanding precise timing and forward directionality. Through single-embryo total RNA sequencing of 2-cell and 8-cell embryos, we find that <italic>Setdb1</italic><sup>mat-/+</sup> embryos fail to extinguish 1-cell and 2-cell transient genes—alongside persistent expression of MERVL retroelements and MERVL-driven chimeric transcripts that define the totipotent state in mouse 2-cell embryos. Comparative bioinformatics reveals that SETDB1 acts at MT2 LTRs and MERVL-driven chimeric transcripts, which normally acquire H3K9me3 during early development. The dysregulated targets substantially overlap with DUXBL-responsive genes, indicating a shared regulatory pathway for silencing the 2-cell transcriptional program. We establish maternal SETDB1 as a critical chromatin regulator required to extinguish retroelement-driven totipotency networks and ensure successful preimplantation development.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>

</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>SETDB1 is a histone 3 lysine 9 (H3K9) di- and tri-methyl transferase [<xref ref-type="bibr" rid="c1">1</xref>]. In the mouse embryo, it localizes to the inner cell mass of the blastocyst [<xref ref-type="bibr" rid="c2">2</xref>] and is essential for postimplantation development [<xref ref-type="bibr" rid="c3">3</xref>]. Homozygous knockout of <italic>Setdb1</italic> results in embryonic lethality between 3.5- and 5.5-days post coitum (dpc) and prevents the derivation of embryonic stem cells (ESCs). SETDB1 is required for the silencing of developmental gene promoters [<xref ref-type="bibr" rid="c4">4</xref>]. Although <italic>Setdb1</italic><sup>-/-</sup> zygotic mutants retain maternally deposited SETDB1 protein from the oocyte, conditional knockout of <italic>Setdb1</italic> during oogenesis produces an earlier and more severe maternal-effect phenotype: most oocytes arrest during meiosis, and the few that are fertilized typically fail to develop beyond the 2-cell or 8-cell stages and never reach the blastocyst [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref>]. The basis of this cleavage-stage arrest in the <italic>Setdb1</italic><sup>mat-/+</sup> embryos remains unknown.</p>
<p>This developmental block coincides with the transition from totipotency to pluripotency, prompting us to investigate whether SETDB1 regulates this critical process. Following fertilization, parental epigenomes undergo extensive reprogramming to enable zygotic genome activation (ZGA). In mice, minor ZGA occurs at the late 1-cell stage and major ZGA at the 2-cell stage—both essential for development [<xref ref-type="bibr" rid="c7">7</xref>]. The 2-cell stage marks the onset of totipotency, while from the 4-cell stage onward, blastomeres begin committing to either the pluripotent inner cell mass or the trophectoderm lineage [<xref ref-type="bibr" rid="c8">8</xref>]. In ESCs, dedifferentiation to 2-cell-like cells (2CLCs) [<xref ref-type="bibr" rid="c9">9</xref>] depends on DUX, a pioneer transcription factor that activates ZGA genes [<xref ref-type="bibr" rid="c10">10</xref>]. Additional ZGA drivers include OBOX, NFYA, NR5A2, and SRF [<xref ref-type="bibr" rid="c10">10</xref>–<xref ref-type="bibr" rid="c15">15</xref>], which open chromatin and activate transcription in a combinatorial or compensatory fashion [<xref ref-type="bibr" rid="c16">16</xref>]. Although DUX and individual OBOX proteins are dispensable for ZGA in embryos [<xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c18">18</xref>], their combined loss [<xref ref-type="bibr" rid="c14">14</xref>], or loss of both DUX and OBOX4 [<xref ref-type="bibr" rid="c19">19</xref>], impairs development, suggesting functional redundancy. While recent studies shed light on ZGA initiation, the mechanisms responsible for extinguishing the 2-cell transcriptional program remain poorly understood.</p>
<p>Endogenous retroviruses (ERVs) are key regulators of early development. MERVL elements are transcriptionally active in 2-cell embryos [<xref ref-type="bibr" rid="c20">20</xref>] and drive chimeric transcripts that define the totipotent state [<xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c21">21</xref>]. MERVL activation is required for blastocyst formation [<xref ref-type="bibr" rid="c22">22</xref>] and is mediated by DUX/OBOX and SRF binding at MT2 long terminal repeats (LTRs) [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c23">23</xref>]. However, sustained MERVL expression—such as that induced by forced DUX expression—disrupts totipotency exit and embryo development [<xref ref-type="bibr" rid="c18">18</xref>, <xref ref-type="bibr" rid="c24">24</xref>]. Although timely repression of MERVLs and the 2-cell program requires DUXBL [<xref ref-type="bibr" rid="c25">25</xref>], the mechanisms by which DUXBL silences totipotency-related genes remain unknown.</p>
<p>Because genome-wide DNA demethylation occurs after fertilization, preimplantation embryos rely heavily on histone modifications to regulate transcription. During cleavage-stage development, H3K9me3 is deposited at retrotransposons; MERVL elements begin to acquire this repressive mark by the 2-cell stage, as DNA methylation levels decline [<xref ref-type="bibr" rid="c26">26</xref>]. SETDB1, a key H3K9 methyltransferase, is thus a strong candidate for regulating MERVL silencing and early embryonic transcriptional control. In ESCs, SETDB1 represses transposable elements (TEs) via TRIM28 (KAP1)-dependent H3K9me3 deposition and by maintaining DNA methylation at LTRs and imprinted DMRs [<xref ref-type="bibr" rid="c27">27</xref>–<xref ref-type="bibr" rid="c29">29</xref>]. However, its role at MERVLs in ESCs is debated: some studies report minimal repression [<xref ref-type="bibr" rid="c30">30</xref>], while others show that SETDB1 silences MERVLs to prevent dedifferentiation into 2CLCs [<xref ref-type="bibr" rid="c31">31</xref>]. In oocytes, <italic>Setdb1</italic> loss leads to derepression of ERVK and ERVL-MaLR retrotransposons [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref>]. Whether SETDB1 also regulates MERVLs and totipotency exit in cleavage-stage embryos remains unresolved.</p>
<p>To address this question and understand why <italic>Setdb1</italic><sup>mat-/+</sup> embryos fail to exit the cleavage stages, we employed a conditional knockout strategy. We previously showed that maternal SETDB1 protects the maternal pronucleus from TET3-mediated DNA demethylation in zygotes [<xref ref-type="bibr" rid="c32">32</xref>]. Here, we investigate its role in preimplantation development by analyzing the transcriptomes of 2-cell and rare 8-cell <italic>Setdb1</italic><sup>mat-/+</sup> embryos. We find that maternally deposited SETDB1 is required to silence MERVL expression and 2-cell-specific totipotency transcripts, enabling successful progression beyond the cleavage stages.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title><italic>Setdb1</italic> maternal knockout embryos fail preimplantation development</title>
<p>A complete understanding of early embryonic development—and its intrinsic directionality and tempo—requires in vivo approaches. To address the in vivo role of SETDB1 in controlling the earliest stages of embryo development we applied a genetic approach. We crossed <italic>Setdb1</italic><sup>f/f</sup>; <italic>Zp3</italic>-cre females with wild-type JF1/Ms males to obtain maternal knockout (<italic>Setdb1</italic><sup>mat-/+</sup>) (KO) embryos. Control <italic>Setdb1</italic><sup>f/f</sup> (WT) embryos were derived from <italic>Setdb1</italic><sup>f/f</sup> females lacking the <italic>Zp3</italic>-cre transgene. We previously reported that H3K9me2 and H3K9me3 histone marks are globally reduced in <italic>Setdb1</italic><sup>mat-/+</sup> zygotes following <italic>Zp3</italic>-cre -driven excision of the SET domain from growing oocytes [<xref ref-type="bibr" rid="c32">32</xref>].</p>
<p>The maternal <italic>Setdb1</italic> transcript is present in oocytes and persists throughout preimplantation development, while zygotic expression from the paternal allele begins only at the blastocyst stage [<xref ref-type="bibr" rid="c3">3</xref>]. Consequently, <italic>Setdb1</italic><sup>mat-/+</sup> embryos lack SETDB1 protein function from the oocyte through the 8-cell stage.</p>
<p>At 1.5 dpc, over 70% of control eggs had reached the 2-cell (2c) stage, with a few progressing to the 4-cell (4c) stage (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). In contrast, fewer than 30% of <italic>Setdb1</italic><sup>mat-/+</sup> eggs reached the 2c stage, with many arrested at GV, MI, or MII stages. By 2.5 dpc, ∼80% of control embryos reached the 8-cell (8c) stage, while only ∼4% of mutant embryos did so. These findings agree with earlier studies [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref>] and show that preimplantation development is severely impacted in <italic>Setdb1</italic><sup>mat-/+</sup> embryos.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Maternal SETDB1 is essential for development beyond the 8-cell stage</title>
<p>(A) Quantification of <italic>Setdb1</italic><sup>mat-/+</sup> (KO) and <italic>Setdb1</italic><sup>fl/+</sup> (WT) embryo stages from the following number of total recovered embryos: KO (n=638), WT (n=484) at 1.5 dpc, and KO (n=310) and WT (n=80) at 2.5 dpc. (B) Principal component analysis of single-embryo total RNA-seq data from 2cWT (n=6), 2cKO (n=15), 8cWT (n=8), and 8cKO (n=8) embryos. (C) Schematic of four pair-wise comparisons defining requirements for normalcy and development. (D) Volcano plots highlighting DEGs using |log₂FC| &gt; 1 and adjusted <italic>P</italic> &lt; 0.05. (E–F) Four-way DEG comparisons visualized by Venn diagrams: (E) downregulated; (F) upregulated. (G–J) Heatmaps of DEGs from Venn compartments, showing stage- and genotype-specific patterns.</p></caption>
<graphic xlink:href="680892v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Single-embryo total RNA sequencing of <italic>Setdb1</italic><sup>mat-/+</sup> embryos</title>
<p>As no <italic>Setdb1</italic><sup>mat-/+</sup> embryos develop into blastocysts, we performed single-embryo RNA sequencing at the 2c and 8c stages (1.5 and 2.5 dpc, respectively) to determine how maternal SETDB1 supports development beyond the cleavage stage. The KO embryos that did develop to the 2c or 8c stage were morphologically indistinguishable from WT under light microscopy (<xref rid="figs1" ref-type="fig">Figure S1A</xref>). To optimally assess both regular and chimeric transcription we used total RNA sequencing. We profiled both KO and WT embryos with &gt;6 biological replicates (<xref rid="tbls1" ref-type="table">Table S1</xref>). Examples of normally expressing transcripts are displayed in <xref rid="figs1" ref-type="fig">Figure S1B</xref>.</p>
<p>Principal component analysis (PCA) revealed that samples clustered primarily by developmental stage (PC1), and secondarily by genotype (PC2) (<xref rid="fig1" ref-type="fig">Figure 1B</xref>), indicating that stage-specific transcriptional programs remain partially impact—more distinctly so in the rare 8-cell stage embryos. We defined differentially expressed genes (DEGs) using thresholds of |log₂FC| &gt; 1 and adjusted <italic>P</italic> &lt; 0.05 across four pair-wise comparisons (<xref rid="fig1" ref-type="fig">Figure 1C</xref>; <xref rid="supp1" ref-type="supp">Table S2</xref>).</p>
<p>Volcano plots (<xref rid="fig1" ref-type="fig">Figure 1D</xref>) visualize the four key comparisons, and we provide the matching gene set enrichment analysis (GSEA) to each pair-wise contrast (<xref rid="figs2" ref-type="fig">Figure S2</xref>; <xref rid="supp2" ref-type="supp">Table S3</xref>): “To be normal” at the 2c (2cWT vs. 2cKO) and 8c (8cWT vs. 8cKO) stages; and “To develop” from 2c to 8c in WT (8cWT vs. 2cWT) and KO (8cKO vs. 2cKO) embryos. The volcano plots and an intersection analysis (<xref rid="fig1" ref-type="fig">Figures 1E–F</xref>) using a four-way Venn diagram approach revealed that most DEGs fell into the “To develop” category, consistent with the PCA results.</p>
</sec>
<sec id="s2c">
<title>Transcriptional programs of development do not collapse in the absence of maternal SETDB1</title>
<p>We first examined DEGs associated with the “To develop” category. We identified 1,722 genes downregulated during development in both WT (8cWT vs. 2cWT) and KO (8cKO vs. 2cKO) embryos (<xref rid="fig1" ref-type="fig">Figure 1E</xref>), suggesting their normal downregulation is not dependent on SETDB1. This trend was confirmed by heatmap clustering (<xref rid="figs3" ref-type="fig">Figure S3A</xref>).</p>
<p>Gene ontology (GO) terms associated with these downregulated DEGs included DNA binding, transcriptional activation, ubiquitination, and phospholipid binding (<xref rid="figs3" ref-type="fig">Figure S3B</xref>; <xref rid="supp3" ref-type="supp">Table S4</xref>). Similarly, 828 genes were consistently upregulated during development in both WT and KO embryos (<xref rid="fig1" ref-type="fig">Figure 1F</xref>) and were enriched in RNA production and translation (<xref rid="figs3" ref-type="fig">Figure S3D</xref>). Together, these results indicate that maternal SETDB1 is not required for the global execution of 2c-to-8c transcriptional transitions, and that the developmental arrest observed is not due to a complete transcriptional collapse.</p>
</sec>
<sec id="s2d">
<title>The two-cell program is misregulated in the absence of maternal SETDB1</title>
<p>To understand which developmental change occurs specifically in <italic>Setdb1</italic><sup>mat-/+</sup> embryos, we focused on genes differentially expressed only in KO embryos during the 2c to 8c transition. We identified 2,379 downregulated and 1,166 upregulated DEGs in the 8cKO vs. 2cKO contrast, but not in the WT developmental comparison (<xref rid="fig1" ref-type="fig">Figures 1E, 1F</xref>).</p>
<p>Heatmaps revealed that many genes exhibited aberrant expression in 2cKO embryos, with levels reverting to near-normal by the 8c stage (<xref rid="figs4" ref-type="fig">Figures S4A, S4C</xref>). Overrepresentation analysis indicated that 2cKO embryos underexpressed genes related to ribosomal and mitochondrial function (<xref rid="figs4" ref-type="fig">Figure S4B</xref>), while overexpressing genes associated with later developmental processes such as pattern specification and organ morphogenesis (<xref rid="figs4" ref-type="fig">Figure S4D</xref>). These observations suggest that mis-timed activation or repression occurs in the absence of maternal SETDB1.</p>
<p>In a related heat map comparison (<xref rid="figs4" ref-type="fig">Figure S4E</xref>), we identified genes uniquely overexpressed in 2cKO embryos that are enriched in ribosomal and mitochondrial pathways (<xref rid="figs4" ref-type="fig">Figure S4F</xref>). Thus, maternal SETDB1 is required to properly regulate 2-cell-stage gene expression dynamics.</p>
</sec>
<sec id="s2e">
<title>Maternal SETDB1 is required for timely suppression of cleavage-stage transcripts</title>
<p>To explore SETDB1’s role in establishing a normal 2c transcriptome, we analyzed 2cWT vs. 2cKO DEGs and found 171 downregulated and 238 upregulated transcripts (<xref rid="fig1" ref-type="fig">Figures 1E, 1F</xref>; <xref rid="supp1" ref-type="supp">Table S2</xref>). Among the 69 downregulated genes exclusive to 2cWT vs. 2cKO, many are prematurely activated in 2cKO embryos, including <italic>Klf10</italic>, <italic>Lig1</italic>, and <italic>H1f3</italic> (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). Another 59 DEGs downregulated in 2cWT vs. 2cKO overlapped with 8cKO vs. 2cKO DEGs and were misexpressed only at the 2c stage (<xref rid="fig1" ref-type="fig">Figure 1H</xref>), suggesting these transcripts are normally repressed by SETDB1 at 2c but not at 8c. Notable example is <italic>Zscan4c</italic>, a key regulator of the 2-cell program in vitro [<xref ref-type="bibr" rid="c33">33</xref>].</p>
<p>To understand SETDB1’s role at the 8c stage, we analyzed 636 downregulated and 302 upregulated DEGs in 8cWT vs. 8cKO embryos (<xref rid="supp1" ref-type="supp">Table S2</xref>). Of these, 270 overlapped with 8cWT vs. 2cWT DEGs (<xref rid="fig1" ref-type="fig">Figure 1E</xref>), indicating that maternal SETDB1 normally suppresses these transcripts during the 2c to 8c transition (<xref rid="fig1" ref-type="fig">Figure 1I</xref>). This group included <italic>Usp17ld</italic>, <italic>Tdpoz1</italic> and <italic>Tdpoz3</italic>, transcripts expressed transiently at the 1-cell, 2-cell or 4-cell stages [<xref ref-type="bibr" rid="c34">34</xref>].</p>
<p>An additional 121 DEGs overlapped with both developmental and genotype comparisons, suggesting that their silencing occurs more slowly in <italic>Setdb1</italic><sup>mat-/+</sup> embryos than in controls (<xref rid="fig1" ref-type="fig">Figure 1J</xref>). These included the 2-cell transient genes [<xref ref-type="bibr" rid="c34">34</xref>] <italic>Obox3</italic> and <italic>Fzd7</italic>, further implicating maternal SETDB1 in regulating 2c-specific transcriptional shutdown. Taken together, this four-way comparison approach highlights maternal SETDB1 as a key factor for the timely suppression of specific transcripts at both the 2-cell and 8-cell stages.</p>
</sec>
<sec id="s2f">
<title>Maternal SETDB1 controls transient gene expression during ZGA</title>
<p>We next asked whether maternal SETDB1 regulates specific ZGA gene classes as defined in the “Database of Transcriptome in Mouse Early Embryos” (DBTMEE) [<xref ref-type="bibr" rid="c34">34</xref>]. Overrepresentation analysis (<xref rid="fig2" ref-type="fig">Figure 2A</xref>; <xref rid="supp4" ref-type="supp">Table S5</xref>) using DBTMEE gene clusters from Sakashita et al. [<xref ref-type="bibr" rid="c22">22</xref>] revealed distinct patterns across four two-way DEG comparisons.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Maternal SETDB1 extinguishes 2-cell transient gene expression</title>
<p>(A) Bubble plot showing overrepresentation analysis of DBTMEE [<xref ref-type="bibr" rid="c34">34</xref>]-defined transcript sets among differentially expressed genes (DEGs) identified in the four pairwise comparisons. (B) IGV browser snapshots of representative transcripts from the DBTMEE-defined minor ZGA to MGA, 2-cell transient, and 4-cell transient gene sets across five biological replicates. Venn diagram compartments are indicated above each track. Unit in brackets represent normalized counts per million (CPM). Bigwig tracks are shown in the transcriptional direction matching the depicted gene. (C) Boxplots of selected DEGs *(|log₂FC| &gt; 1, adjusted <italic>P</italic> &lt; 0.05) from each Venn compartment, based on data from 2cWT (n=6), 2cKO (n=15), 8cWT (n=8), and 8cKO (n=8) embryos.</p></caption>
<graphic xlink:href="680892v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Maternal RNA and minor ZGA genes were appropriately downregulated in both WT and KO embryos from the 2c to 8c stage, as expected during normal development. However, 2-cell-specific transient transcripts were significantly downregulated in 8cWT vs. 2cWT embryos but not in 8cKO vs. 2cKO embryos. Moreover, 8cWT vs. 8cKO downregulated DEGs were enriched in this gene set, indicating a requirement for maternal SETDB1 to suppress 2c-transient transcripts by the 8c stage.</p>
<p>Similarly, 1-cell transient genes at the 2c stage and minor ZGA genes at the 8c stage were also insufficiently silenced in KO embryos. By contrast, mid-preimplantation gene activation (MGA) genes and their upstream regulators were upregulated normally in both genotypes. Notably, major ZGA and mid-preimplantation gene activity (MGA) transition-related genes were also underexpressed in 2cKO embryos, suggesting that SETDB1 may also support their proper induction.</p>
<p>Representative IGV browser tracks illustrate misregulation patterns in 5 biological replicates per condition (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), including <italic>Zscan4c</italic> (minor ZGA), <italic>Usp17ld</italic> (<italic>Dub1b</italic>) (1-cell transient) <italic>Dbf4</italic> (2c transient), and <italic>Tdpoz3</italic> (4c transient). Differential expression status is mapped across Venn diagram segments (<xref rid="fig1" ref-type="fig">Figure 1E</xref>), and selected transcripts are shown in boxplots (<xref rid="fig2" ref-type="fig">Figure 2C</xref>).</p>
<p>These results demonstrate that maternal SETDB1 is required to suppress 1-cell transient genes by the 2c stage, and minor ZGA and 2c-specific genes by the 8c stage, ensuring transcriptional fidelity across cleavage stages.</p>
</sec>
<sec id="s2g">
<title>Maternal SETDB1 suppresses 2-cell-specific MERVL-chimeric transcripts</title>
<p>MERVL retroelements act as alternative promoters for chimeric transcripts during the 2-cell stage and serve as molecular hallmarks of totipotency [<xref ref-type="bibr" rid="c9">9</xref>]. Although SETDB1 represses ERVK and ERVL-MaLR retrotransposons in oocytes, it does not affect MERVLs at that stage [<xref ref-type="bibr" rid="c6">6</xref>].</p>
<p>We found significantly higher transcript levels of <italic>MERVLint:ERVL:LTR</italic> and <italic>MT2_Mm:ERVL:LTR</italic> in 2cKO than in 2cWT embryos (<xref rid="fig3" ref-type="fig">Figure 3A</xref>; <xref rid="supp5" ref-type="supp">Table S6</xref>). These transcripts were efficiently extinguished in WT embryos by the 8c stage but remained partially expressed in KO embryos. The difference was even more pronounced at 8c: <italic>MT2</italic> expression was downregulated in 8cWT vs. 8cKO with LFC = –2.65 and adj. <italic>P</italic> = 1.31E–16, compared to LFC = –1.86 and adj. <italic>P</italic> = 1.41E–08 in 2cWT vs. 2cKO.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Maternal SETDB1 regulates MERVL-driven chimeric transcripts</title>
<p>(A) Boxplots showing normalized counts of multimapped MERVL-int and MT2_Mm elements. (B) Heatmap from <italic>Setdb1</italic> KO embryos at MERVL chimeric transcripts classified by Macfarlan [<xref ref-type="bibr" rid="c9">9</xref>]. (C–D) Volcano plots marking Macfarlan-defined chimeric transcripts in 2cWT vs. 2cKO and 8cWT vs. 8cKO pairwise comparisons. (E) IGV browser images of MT2B1 LTR-driven MERVL-chimeric transcripts. (F) Venn diagram showing differentially expressed (<italic>P</italic> &lt; 0.05) known and novel TE-driven chimeric transcripts.</p></caption>
<graphic xlink:href="680892v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Similarly, many MERVL chimeric transcripts defined by Macfarlan et al. [<xref ref-type="bibr" rid="c9">9</xref>] were upregulated in both 2cKO and 8cKO embryos (<xref rid="fig3" ref-type="fig">Figure 3B</xref>), with most clustering on the left side of volcano plots (downregulated in WT vs. KO) (<xref rid="fig3" ref-type="fig">Figure 3C-D</xref>). Two shared DEGs reached significance at 2c, and nine at 8c (<italic>P</italic> adj &lt; 0.05, |log₂FC| &gt; 1). IGV views show misregulation of representative transcripts <italic>Slc19a3</italic> and <italic>Trak2</italic> (<xref rid="fig3" ref-type="fig">Figure 3E</xref>).</p>
<p>Using a combined list of previously identified [<xref ref-type="bibr" rid="c35">35</xref>] and novel chimeric transcripts we performed a four-way comparison to assess SETDB1 dependency (<xref rid="fig3" ref-type="fig">Figure 3F</xref>; <xref rid="supp5" ref-type="supp">Table S6</xref>). SETDB1 had a strong suppressive effect on TE-driven, including MERVL-driven transcripts at both 2c and 8c stages, with no clear activating role. Thus, maternal SETDB1 is essential to silence 2c-specific MERVL chimeric transcripts during preimplantation development.</p>
</sec>
<sec id="s2h">
<title>Maternal SETDB1 silences MERVL MT2 LTR-activated transcripts</title>
<p>MT2s represent major MERVL subfamilies and their LTRs can act as alternative promoters or distal enhancers, depending on their genomic position and orientation. A recent study by Yang et al. [<xref ref-type="bibr" rid="c23">23</xref>] used a CRISPR-based epigenetic MT2 LTR inactivation system (MT2i) to identify MT2-controlled genes in mouse embryos. Using ChIP-seq data from Wang et al. [<xref ref-type="bibr" rid="c26">26</xref>] we found that H3K9me3 deposition at MT2-dependent transcripts is first reduced between E2c and L2c but later increases from 4c to the 8c stage (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). MT2s that drive those transcripts accumulate H3K9me3 peaks progressively from the E2c to 8c stages (<xref rid="fig4" ref-type="fig">Figure 4B</xref>), and these peaks are stronger and more spatially defined. Peaks localized at the MT2 edges is consistent with low internal mappability in repeat elements. IGV browser views show that the expression of MT2-controlled DEGs such as <italic>Arsk</italic> and <italic>Usp17ld</italic> was derepressed in 2cKO and 8cKO embryos while their flanking MERVLs and MT2s display strong H3K9me3 peaks in WT embryos (<xref rid="fig4" ref-type="fig">Figures 4C–E</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Maternal SETDB1 suppresses MT2 LTR-regulated genes</title>
<p>(A–B) Heatmaps of H3K9me3 deposition [<xref ref-type="bibr" rid="c26">26</xref>] at MT2-controlled [<xref ref-type="bibr" rid="c23">23</xref>] DEGs (A) and their MT2 elements (B) across early embryonic stages. (C–E) IGV browser views of a representative MERVL and MT2-regulated loci. (F) Heatmap of maternal <italic>Setdb1</italic> KO embryos at DEGs classified by MT2i data. (G–H) Volcano plots highlighting MT2-regulated genes in 2cWT vs. 2cKO and 8cWT vs. 8cKO pairwise comparisons.</p></caption>
<graphic xlink:href="680892v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Volcano plots reveal that the expression of MT2-controlled DEGs in general was derepressed in 2cKO and 8cKO embryos (<xref rid="fig4" ref-type="fig">Figures 4F–H</xref>). These genes clustered on the left of volcano plots, indicating strong SETDB1-mediated repression. Yang et al. [<xref ref-type="bibr" rid="c23">23</xref>] identified 341 genes requiring MT2 for activation by early 2c (E2c) and 1,111 by late 2c (L2c). We observed that many of these genes were derepressed in SETDB1 KO embryos (<xref rid="fig5" ref-type="fig">Figures 5A–E</xref>). These results provide genetic evidence that maternal SETDB1 is essential for silencing MT2-activated genes.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>SETDB1 regulates MT2-activated genes across time</title>
<p>(A) Heatmaps comparing MT2i-responsive [<xref ref-type="bibr" rid="c23">23</xref>] early two cell (E2c) DEGs with the <italic>Setdb1</italic> KO transcriptomes. (B, C) Volcano plots highlighting MT2-regulated E2c DEGs in 2cWT vs. 2cKO and 8cWT vs. 8cKO pairwise comparisons. (D) Heatmaps of MT2i late two cell (L2c) DEGs. (E) Volcano plot highlighting MT2-regulated L2c DEGs.</p></caption>
<graphic xlink:href="680892v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2i">
<title>Maternal SETDB1 has a broad effect on transposable elements in 2c and 8c embryos</title>
<p>We next examined whether maternal SETDB1 broadly regulates TE expression during preimplantation. PCA of TE expression in our RNA-seq data revealed clustering first by stage and then by genotype, with increased variability among 8cKO samples (<xref rid="figs5" ref-type="fig">Figure S5A</xref>). We analyzed both multimapped and uniquely mapped TE reads. Multimapped TE analysis (<xref rid="figs5" ref-type="fig">Figure S5B</xref>; <xref rid="supp6" ref-type="supp">Table S7</xref>) showed that maternal SETDB1 is required to suppress TEs in WT vs. KO embryos and plays a role during 2c to 8c development.</p>
<p>The tallies of “To be normal” DE TEs by TE families show that several TE families— including ERVK, ERVL, ERVL-MaLR, ERV1, and L1 elements—require suppression by SETDB1 in WT embryos (<xref rid="figs5" ref-type="fig">Figure S5C</xref>). The ERVK, ERVL-MaLR, and ERV1 families were most affected in both 2cWT vs. 2cKO and 8cWT vs. 8cKO contrasts, while LINEs required SETDB1 for repression mainly at 2c. The tallies of “To develop” suggest that SETDB also affects developmental TE changes during 2c-to-8c transitions. ERVK and LINE-1 elements appear to be developmentally activated in WT but less so in KO embryos (<xref rid="figs5" ref-type="fig">Figure S5D</xref>), which we investigate further below.</p>
<p>Heatmaps of “To be normal” DE TEs (<xref rid="figs5" ref-type="fig">Figure S5E</xref>) revealed strong derepression of nearly all repeat families in KO embryos at both the 2c and 8c stages. Heatmaps of “To develop” DE TEs (<xref rid="figs5" ref-type="fig">Figure S5F</xref>) clarify how developmental changes are affected by SETDB1. In WT embryos, L1 LINEs and many ERVKs were upregulated between 2c and 8c, while MERVLs and ERVL-MaLRs were appropriately silenced. This developmental regulation was disrupted in KO embryos: 8cKO vs. 2cKO showed partial MERVL/ERV1 repression and inappropriate activation of some ERVKs and LINEs—due to the highly derepressed state in 2cKO embryos. The analysis of uniquely mapped TE transcripts in presented in <xref rid="supp7" ref-type="supp">Table S8</xref>.</p>
<p>These results collectively show that maternal SETDB1 is a major regulator of TE expression, with broad effects extending beyond MERVLs to multiple TE families during early development.</p>
</sec>
<sec id="s2j">
<title>Maternal SETDB1 is required to extinguish DUXBL-responsive transcripts</title>
<p>DUXBL is a known repressor of ZGA and MERVL genes, acting in the footsteps of DUX during the exit from totipotency [<xref ref-type="bibr" rid="c25">25</xref>]. We tested whether maternal SETDB1 is required for DUXBL-mediated suppression. We compared our RNA-seq data to the top 50 DEGs from <italic>Duxbl</italic><sup>-/-</sup> embryos [<xref ref-type="bibr" rid="c25">25</xref>] and found that 7 and 12 DUXBL-suppressed transcripts were derepressed in 2cKO, and 8cKO embryos, respectively (<xref rid="fig6" ref-type="fig">Figure 6A</xref>), suggesting that maternal SETDB1 acts specifically in their silencing. Volcano plots (<xref rid="fig6" ref-type="fig">Figure 6B</xref>) showed DUXBL-upregulated genes clustering on the left in both 2cWT vs. 2cKO and 8cWT vs. 8cKO comparisons, indicating again SETDB1-dependent suppression.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>SETDB1 represses DUXBL-responsive transcripts</title>
<p>(A) Heatmap of top 50 DEGs identified in <italic>Duxbl</italic> KO embryos [<xref ref-type="bibr" rid="c25">25</xref>] analyzed in the <italic>Setdb1</italic> KO RNA-seq dataset. (B) Volcano plots marking up-/downregulated DUXBL targets in 2cWT vs. 2cKO and 8cWT vs. 8cKO pairwise comparisons. (D–E) IGV browser examples of DUXBL-responsive DEGs with aligned H3K9me3 ChIP-seq data.</p></caption>
<graphic xlink:href="680892v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>IGV browser views confirmed that <italic>Dennd4c</italic> (2c), <italic>Tmem132c</italic>, <italic>Antxr1</italic>, and <italic>Aqr</italic> (8c) were derepressed in KO embryos and associated with H3K9me3 peaks flanking MERVL elements in WT embryos (<xref rid="fig6" ref-type="fig">Figures 6D–E</xref>; <xref rid="figs6" ref-type="fig">S6A–B</xref>). Although H3K9me3 signal within MERVLs is low due to mappability limits, adjacent flanks exhibited strong enrichment beginning at the 2c stage and increasing through 4c to morula Wang et al. [<xref ref-type="bibr" rid="c26">26</xref>] Two additional genes, <italic>Nelfa</italic> and <italic>Zscan4d</italic>, appeared derepressed in KO embryos (<xref rid="figs6" ref-type="fig">Figure S6C–D</xref>), despite not crossing significance thresholds. MERVLs serve as alternative promoters or distal enhancers for these transcripts, with H3K9me3 deposited near these elements in WT but not KO embryos.</p>
<p>Together, these data provide genetic evidence that DUXBL requires maternal SETDB1 to silence a subset of its targets via H3K9me3 deposition at MERVL LTRs.</p>
</sec>
<sec id="s2k">
<title>Overrepresentation analysis confirms shared targets with MT2 and DUXBL pathways</title>
<p>We performed ORA to test for overlap between SETDB1-sensitive genes and those reported by Yang et al. (MT2i) [<xref ref-type="bibr" rid="c23">23</xref>] and Vega-Sendino et al. (DUXBL KO) [<xref ref-type="bibr" rid="c25">25</xref>] (<xref rid="fig7" ref-type="fig">Figure 7A</xref>; <xref rid="supp8" ref-type="supp">Table S9</xref>). We found highly significant overlap between: Proximal MT2-controlled DEGs and DEGs downregulated in 2cWT vs. 2cKO (adj. <italic>P</italic> = 3.19E–04); Proximal MT2-controlled DEGs and DEGs in 8cWT vs. 8cKO (adj. <italic>P</italic> = 7.17E–04); E2c MT2i-downregulated genes and SETDB1-repressed DEGs at 2c (adj. <italic>P</italic> = 8.18E–05); and E2c MT2i-downregulated genes and SETDB1-repressed DEGs at 8c (adj. <italic>P</italic> = 5.77E–11). This suggests that genes activated by MT2s during ZGA also require maternal SETDB1 for their timely silencing later.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>SETDB1 collaborates with DUXBL to repress totipotency programs</title>
<p>(A) Bubble plot of overrepresentation analysis showing enrichment of previously identified MERVL-chimeric, MT2i-responsive and <italic>Duxbl</italic> KO-responsive gene sets [<xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c25">25</xref>] in <italic>Setdb1</italic> KO pairwise DEGs. (B) Summary model: Maternal SETDB1 deposits H3K9me3 at MT2 elements to silence MERVL-driven 2-cell transcripts in coordination with DUXBL, enabling exit from totipotency.</p></caption>
<graphic xlink:href="680892v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We also observed strong enrichment between DUXBL-suppressed genes and SETDB1-repressed DEGs in 8cWT vs. 8cKO embryos (<italic>P</italic> adj = 0.0071), supporting a cooperative role in extinguishing the 2c program.</p>
<p>In summary, these findings establish SETDB1, a H3K9 methyltransferase, as a broad-acting chromatin regulator in the preimplantation-stage embryo required for: silencing MERVL retroviral elements; extinguishing minor ZGA and transient totipotency-associated genes; and terminating transcription of MT2-activated and DUXBL-regulated transcripts at key regulatory elements in cleavage-stage embryos.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>SETDB1 is essential for mammalian development due to its role in establishing transcriptionally repressive H3K9me3 marks. Our findings indicate that the maternal-effect lethality observed in <italic>Setdb1</italic><sup>mat-/+</sup> preimplantation embryos is not due to a global transcriptional collapse, but rather the failure to silence specific transcriptional programs that must be extinguished for normal progression through, and beyond, the cleavage stages. Exit from the totipotency state is essential for embryonic development [<xref ref-type="bibr" rid="c18">18</xref>, <xref ref-type="bibr" rid="c24">24</xref>]. While SETDB1 affects a broad range of genes and retroelements during preimplantation development, its specific role in silencing the totipotency program alone underscores its critical role as a chromatin regulator in early embryogenesis.</p>
<p>Maternal SETDB1 functions in a highly specific and dynamic manner. At the 2-cell stage, it suppresses 1-cell transient and minor ZGA transcripts; by the 8-cell stage, it silences 2-cell transient and MERVL-associated chimeric transcripts. In normal development, these silencing events coincide with dynamic H3K9me3 deposition at MERVLs and MT2 LTRs. In ESCs, SETDB1 prevents dedifferentiation into 2-cell-like cells by depositing H3K9me3 at or near totipotency genes [<xref ref-type="bibr" rid="c31">31</xref>], suggesting that a similar mechanism may operate during embryo development in vivo. However, the rarity of <italic>Setdb1</italic><sup>mat-/+</sup> 8-cell embryos limits our ability to directly confirm H3K9me3 depletion at these loci—a limitation of this study.</p>
<p>SETDB1’s mechanism likely involves recruitment to specific retroelement loci, such as MT2 LTRs by transcription factors, such as DUXBL. Our genetic data show that SETDB1 is required for silencing both MT2 LTRs and DUXBL-responsive transcripts. The overlap of SETDB1-regulated genes with those affected by MT2 inactivation [<xref ref-type="bibr" rid="c23">23</xref>] and DUXBL loss [<xref ref-type="bibr" rid="c25">25</xref>], along with the presence of H3K9me3 at these loci during normal preimplantation development, suggests a coordinated silencing mechanism in the embryo. Phenotypic parallels between <italic>Setdb1</italic><sup>mat-/+</sup> and <italic>Duxbl</italic><sup>-/-</sup> embryos support this model. While <italic>Duxbl</italic><sup>-/-</sup> embryos arrest at the 4-cell stage [<xref ref-type="bibr" rid="c25">25</xref>], a few <italic>Setdb1</italic><sup>mat-/+</sup> embryos progress to the 8-cell stage, suggesting that SETDB1 may act redundantly with, or downstream of, DUXBL.</p>
<p>In conclusion, we identify maternal SETDB1 as a critical in vivo epigenetic regulator that extinguishes totipotency-associated transcriptional programs, particularly those driven by retroelements and responsive to DUXBL. Its role at MT2 elements supports a model in which SETDB1 provides an epigenetic memory, silencing retroelements shortly after their activation by DUX and OBOX. This mechanism rapidly restricts the 2-cell transcriptional program, enabling the transition to pluripotency. By repressing MT2 LTRs, SETDB1 ensures successful progression beyond the cleavage stages and supports the earliest cell fate transitions in the mammalian embryo (<xref rid="fig7" ref-type="fig">Figure 7B</xref>).</p>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Mice</title>
<p>All animal experiments were conducted in accordance with the National Research Council’s Guide for the Care and Use of Laboratory Animals, under Institutional Animal Care and Use Committee-approved protocols at Van Andel Institute (VAI). The <italic>Setdb1</italic> conditional knockout mouse line (<italic>Setdb1</italic><sup>f/f</sup>) was derived from <italic>Setdb1</italic><sup>tm1a(EUCOMM)Wtsi</sup> (European Mouse Mutant Archive) as previously described [<xref ref-type="bibr" rid="c32">32</xref>]. The <italic>Pgk</italic>-neo cassette was removed via FLPE-mediated recombination using B6.Cg-Tg<sup>(Pgk1-flpo)10Sykr/J</sup> (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:IMSR_JAX:011065">RRID:IMSR_JAX:011065</ext-link>) [<xref ref-type="bibr" rid="c36">36</xref>]. <italic>Zp3</italic>-cre transgenic mice C57BL/6-Tg<sup>(Zp3-cre)93Knw/J</sup> [<xref ref-type="bibr" rid="c37">37</xref>] were used to excise SET-domain–encoding exons in growing oocytes. <italic>Setdb1</italic><sup>f/f</sup>; <italic>Zp3</italic>-cre females were experimental animals; <italic>Setdb1</italic><sup>f/f</sup> females without the transgene served as controls.</p>
</sec>
<sec id="s4b">
<title>Collection of preimplantation mouse embryos</title>
<p>Embryos were collected at late 2-cell and 8-cell stages. For 2-cell embryos, 6–8-week-old females were superovulated with 5 IU PMSG followed by 5 IU hCG after 46–48 h, then mated with WT males. For 8-cell embryos, CARD HyperOva was used in 26–30-day-old females to increase efficiency. Embryos were harvested in M2 medium at 44 h (1.5 dpc, 2-cell) and 68 h (2.5 dpc, 8-cell) post-hCG. Embryos were washed in PBS, placed into 1.5 mL tubes, lysed in RNA-Bee, flash frozen, and stored at –80 °C.</p>
</sec>
<sec id="s4c">
<title>RNA isolation</title>
<p>RNA was isolated from single embryos using RNA-Bee. Linear polyacrylamide (LPA) was used for carrier-mediated isopropanol precipitation. RNasin® (Promega) was added during resuspension. DNA contamination was removed using rDNase I (Ambion). RNA was recovered after DNase inactivation and ethanol precipitation and eluted in RNasin-containing Tris buffer.</p>
</sec>
<sec id="s4d">
<title>Library preparation and sequencing</title>
<p>Libraries were prepared with the SMART-Seq Stranded Kit (Takara). Samples were randomized and processed with fragmentation to 250 bp (85 °C, 10 min embryo RNA or 6 min control RNA). Unique dual indexes were added during PCR1 (10 cycles), and 8 samples were pooled for PCR2 (12 cycles). Libraries were QC’d using Agilent chips, QuantiFluor®, and KAPA qPCR, and sequenced on a NovaSeq S2 (paired-end 50 bp, ∼25M reads/library).</p>
</sec>
<sec id="s4e">
<title>RNA-seq analysis</title>
<p>Reads were trimmed using Trim Galore (v0.60) [<xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c39">39</xref>] and aligned to mm10 with STAR (v2.7.8) [<xref ref-type="bibr" rid="c40">40</xref>] using --quantMode GeneCounts. DGE analysis was performed with edgeR (v4.4.1) [<xref ref-type="bibr" rid="c41">41</xref>–<xref ref-type="bibr" rid="c43">43</xref>], using Benjamini-Hochberg adjustment (adjusted <italic>P</italic>&lt;0.05). Normalized log<sub>2</sub> counts were used in figures. Bigwig tracks were created using bamCoverage (deepTools v3.5.2, CPM normalization) [<xref ref-type="bibr" rid="c44">44</xref>]. Gene set enrichment analysis (GSEA) and overrepresentation analysis (ORA) against gene ontology (GO) and custom gene sets were performed with ClusterProfiler (v4.14.4) (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_016884">RRID:SCR_016884</ext-link>) [<xref ref-type="bibr" rid="c45">45</xref>].</p>
</sec>
<sec id="s4f">
<title>Transposable element (TE) analysis</title>
<p>Two sets of data were analyzed for TE: multimapped reads and uni-mapped reads. For multimapped reads, STAR (v2.7.8) [<xref ref-type="bibr" rid="c40">40</xref>] was run with --winAnchorMultimapNmax 200, -- outFilterMultimapNmax 100, and --outSAMmultNmax 1. TEtranscripts (v2.2.3) [<xref ref-type="bibr" rid="c46">46</xref>] was used for multi-mapped TE counts. Uni-mapped reads were filtered with -q 255 using Samtools (v1.17) (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_002105">RRID:SCR_002105</ext-link>) [<xref ref-type="bibr" rid="c47">47</xref>]. FeatureCounts (Subread v2.0.0) [<xref ref-type="bibr" rid="c48">48</xref>] was used with mm10_rmsk_TE.gtf to generate count matrices Differential expression was assessed using DESeq2 (v1.46.0) [<xref ref-type="bibr" rid="c49">49</xref>].</p>
</sec>
<sec id="s4g">
<title>Chimeric transcript analysis</title>
<p>Chimeric transcripts were quantified with Retrotransposon (v37), which uses STAR [<xref ref-type="bibr" rid="c48">48</xref>] and StringTie2 [<xref ref-type="bibr" rid="c50">50</xref>]. Count tables were processed using DESeq2 (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_000154">RRID:SCR_000154</ext-link>) [<xref ref-type="bibr" rid="c49">49</xref>] for DGE (adjusted <italic>P</italic>&lt;0.05).</p>
</sec>
<sec id="s4h">
<title>Public datasets</title>
<p>ChIP-seq fastq files [<xref ref-type="bibr" rid="c26">26</xref>] (GSE98149) were trimmed using Trim Galore (v0.60) [<xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c39">39</xref>], aligned to mm10 with BWA (v0.7.1) (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_010910">RRID:SCR_010910</ext-link>) [<xref ref-type="bibr" rid="c51">51</xref>], and filtered with Samtools (v1.17) (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_002105">RRID:SCR_002105</ext-link>) [<xref ref-type="bibr" rid="c47">47</xref>]. BAMs were converted to BigWig and visualized with deepTools [<xref ref-type="bibr" rid="c44">44</xref>]. Supplementary data was used from other studies [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c34">34</xref>], for comparative analyses.</p>
</sec>
<sec id="s4i">
<title>Data visualization</title>
<p>Heatmaps were generated with ComplexHeatmap (R) [<xref ref-type="bibr" rid="c52">52</xref>]., bubble plots were generated using ggplot2 [<xref ref-type="bibr" rid="c53">53</xref>], and Venn diagrams using ggvenn (v0.1.10) [<xref ref-type="bibr" rid="c54">54</xref>].</p>
</sec>
</sec>
</body>
<back>
<sec id="s7" sec-type="supplementary">
<title>Supplementary data</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Figure S1.</label>
<caption><title>Normal features of <italic>Setdb1</italic> KO embryos</title>
<p>(A) Morphology. Brightfield images of 2c and 8c WT and KO embryos at 1.5 and 2.5 dpc. Scale bar 50 µM. (B) Transcription. Single embryo total RNA sequencing results of 2c and 8c WT and KO embryos at 1.5 and 2.5 dpc (n=5). IGV browser views of selected transcripts, with normalized CPM scales shown in brackets.</p></caption>
<graphic xlink:href="680892v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Figure S2.</label>
<caption><title>Gene set enrichment analyis (GSEA) of <italic>Setdb1</italic> KO DEGs</title>
<p>(A–D) Bubble plots of GSEA for 2cWT vs. 2cKO, 8cWT vs. 8cKO, 8cWT vs. 2cWT, and 8cKO vs. 2cKO pairwise comparisons.</p></caption>
<graphic xlink:href="680892v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Figure S3.</label>
<caption><title>Developmental transcriptional changes independent of maternal SETDB1</title>
<p>(A, C) Heatmaps of DEGs commonly downregulated (n=1722) or upregulated (n=828) from 2c to 8c stages. (B, D) GO analysis of those DEGs.</p></caption>
<graphic xlink:href="680892v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Figure S4.</label>
<caption><title>Developmental misregulation in <italic>Setdb1</italic> KO embryos</title>
<p>(A, C, E) Heatmaps showing DEGs uniquely changed in KO embryos. (B, D, F) GO enrichment analyses of these misregulated gene sets.</p></caption>
<graphic xlink:href="680892v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Figure S5.</label>
<caption><title>SETDB1 suppresses transposable elements at cleavage stages</title>
<p>(A) PCA of multimapped TE profiles. (B) Venn diagram of DE TE families (adjusted <italic>P</italic> &lt; 0.05). (C–D) DE TE tallies across pairwise comparisons by TE class. (E-F) DE TE heatmaps across pairwise comparisons by TE class.</p></caption>
<graphic xlink:href="680892v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs6" position="float" orientation="portrait" fig-type="figure">
<label>Figure S6.</label>
<caption><title>Examples of DUXBL targets derepressed in <italic>Setdb1</italic> KO embryos</title>
<p>(A–D) IGV images of <italic>Duxbl</italic> KO DEGs (e.g., <italic>Antxr1</italic>, <italic>Aqr</italic>, <italic>Nelfa</italic>, <italic>Zscan4d</italic>) with associated H3K9me3 profiles. MERVL insertions upstream or intronic are indicated.</p></caption>
<graphic xlink:href="680892v1_figs6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<table-wrap id="tbls1" orientation="portrait" position="float">
<label>Table S1.</label>
<caption><title>Sample Information</title><p>Details of all single embryos analyzed in the study, including genotype, developmental stage, and sequencing sample ID.</p></caption>
<graphic xlink:href="680892v1_tbls1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="680892v1_tbls1a.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We gratefully acknowledge the support from the Van Andel Institute (VAI) Genomics Core (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_022913">RRID:SCR_022913</ext-link>), the VAI Bioinformatics and Biostatistics Core (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_024762">RRID:SCR_024762</ext-link>) and the VAI Vivarium (<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:SCR_023211">RRID:SCR_023211</ext-link>). This work was supported by the Van Andel Institute.</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>RNA sequence data were deposited in GEO (accession number GSE269417). All data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for all figures.</p>
</sec>
</sec>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Table S2.</label>
<caption><title>Differential Gene Expression (DGE) Analysis.</title></caption>
<media xlink:href="Zeng_Table_S2_DGEs.xlsx"/>
</supplementary-material>
<supplementary-material id="supp2">
<label>Table S3.</label>
<caption><title>Gene Set Enrichment Analysis (GSEA) on Gene ontology (GO).</title></caption>
<media xlink:href="Zeng_Table_S3_GSE.xlsx"/>
</supplementary-material>
<supplementary-material id="supp3">
<label>Table S4.</label>
<caption><title>Overrepresentation Analysis (ORA) against Gene Ontology (GO) Analysis by DEG Venn Compartment.</title></caption>
<media xlink:href="Zeng_Table_S4_ORA.xlsx"/>
</supplementary-material>
<supplementary-material id="supp4">
<label>Table S5.</label>
<caption><title>Overrepresentation Analysis (ORA) with DBTMEE Categories.</title></caption>
<media xlink:href="Zeng_Table_S5_ORA_DBTMEE.xlsx"/>
</supplementary-material>
<supplementary-material id="supp5">
<label>Table S6.</label>
<caption><title>Chimeric Transcript Analysis.</title></caption>
<media xlink:href="Zeng_Table_S6_Chimeric_transcripts.xlsx"/>
</supplementary-material>
<supplementary-material id="supp6">
<label>Table S7.</label>
<caption><title>Differential TE Expression (DTE) – Multimapping Reads.</title></caption>
<media xlink:href="Zeng_Table_S7_DTE_multipammed.xlsx"/>
</supplementary-material>
<supplementary-material id="supp7">
<label>Table S8.</label>
<caption><title>Differential TE Expression (DTE) – Unimapping Reads.</title></caption>
<media xlink:href="Zeng_Table_S8_TE_unimapped.xlsx"/>
</supplementary-material>
<supplementary-material id="supp8">
<label>Table S9.</label>
<caption><title>ORA with MERVL-Chimeric, MT2i, and <italic>Duxbl</italic> KO Gene Sets.</title></caption>
<media xlink:href="Zeng_Table_S9_ORA_MT2i_Duxbl_KO.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor</article-title>. <source>Oncogene</source>, <year>2002</year>. <volume>21</volume>(<issue>1</issue>): p. <fpage>148</fpage>–<lpage>52</lpage>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cho</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Dynamics of Setdb1 expression in early mouse development</article-title>. <source>Gene Expr Patterns</source>, <year>2012</year>. <volume>12</volume>(<issue>5-6</issue>): p. <fpage>213</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dodge</surname>, <given-names>J.E.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Histone H3-K9 methyltransferase ESET is essential for early development</article-title>. <source>Mol Cell Biol</source>, <year>2004</year>. <volume>24</volume>(<issue>6</issue>): p. <fpage>2478</fpage>–<lpage>86</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bilodeau</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state</article-title>. <source>Genes &amp; Development</source>, <year>2009</year>. <volume>23</volume>(<issue>21</issue>): p. <fpage>2484</fpage>–<lpage>2489</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eymery</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>The methyltransferase Setdb1 is essential for meiosis and mitosis in mouse oocytes and early embryos</article-title>. <source>Development</source>, <year>2016</year>. <volume>143</volume>(<issue>15</issue>): p. <fpage>2767</fpage>–<lpage>79</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse</article-title>. <source>PLoS Genet</source>, <year>2016</year>. <volume>12</volume>(<issue>4</issue>): p. <fpage>e1005970</fpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abe</surname>, <given-names>K.I.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Minor zygotic gene activation is essential for mouse preimplantation development</article-title>. <source>Proc Natl Acad Sci U S A</source>, <year>2018</year>. <volume>115</volume>(<issue>29</issue>): p. <fpage>E6780</fpage>–<lpage>E6788</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piotrowska-Nitsche</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Four-cell stage mouse blastomeres have different developmental properties</article-title>. <source>Development</source>, <year>2005</year>. <volume>132</volume>(<issue>3</issue>): p. <fpage>479</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Macfarlan</surname>, <given-names>T.S.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Embryonic stem cell potency fluctuates with endogenous retrovirus activity</article-title>. <source>Nature</source>, <year>2012</year>. <volume>487</volume>(<issue>7405</issue>): p. <fpage>57</fpage>–<lpage>63</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Iaco</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>DUX-family transcription factors regulate zygotic genome activation in placental mammals</article-title>. <source>Nat Genet</source>, <year>2017</year>. <volume>49</volume>(<issue>6</issue>): p. <fpage>941</fpage>–<lpage>945</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Iaco</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>DUX is a non-essential synchronizer of zygotic genome activation</article-title>. <source>Development</source>, <year>2020</year>. <volume>147</volume>(<issue>2</issue>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gassler</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Zygotic genome activation by the totipotency pioneer factor Nr5a2</article-title>. <source>Science</source>, <year>2022</year>. <volume>378</volume>(<issue>6626</issue>): p. <fpage>1305</fpage>–<lpage>1315</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hermant</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>The transcription factor SRF regulates MERVL retrotransposons and gene expression during zygotic genome activation</article-title>. <source>Genes Dev</source>, <year>2025</year>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ji</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>OBOX regulates mouse zygotic genome activation and early development</article-title>. <source>Nature</source>, <year>2023</year>. <volume>620</volume>(<issue>7976</issue>): p. <fpage>1047</fpage>–<lpage>1053</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Establishing Chromatin Regulatory Landscape during Mouse Preimplantation Development</article-title>. <source>Cell</source>, <year>2016</year>. <volume>165</volume>(<issue>6</issue>): p. <fpage>1375</fpage>–<lpage>1388</lpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kojima</surname>, <given-names>M.L.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Hoppe</surname></string-name>, and <string-name><given-names>A.J.</given-names> <surname>Giraldez</surname></string-name></person-group>, <article-title>The maternal-to-zygotic transition: reprogramming of the cytoplasm and nucleus</article-title>. <source>Nat Rev Genet</source>, <year>2025</year>. <volume>26</volume>(<issue>4</issue>): p. <fpage>245</fpage>–<lpage>267</lpage>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>Z.</given-names></string-name> and <string-name><given-names>Y.</given-names> <surname>Zhang</surname></string-name></person-group>, <article-title>Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development</article-title>. <source>Nat Genet</source>, <year>2019</year>. <volume>51</volume>(<issue>6</issue>): p. <fpage>947</fpage>–<lpage>951</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Precise temporal regulation of Dux is important for embryo development</article-title>. <source>Cell Res</source>, <year>2019</year>. <volume>29</volume>(<issue>11</issue>): p. <fpage>956</fpage>–<lpage>959</lpage>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Obox4 promotes zygotic genome activation upon loss of Dux</article-title>. <source>eLife</source>, <year>2024</year>. <volume>13</volume>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Svoboda</surname>, <given-names>P.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>RNAi and expression of retrotransposons MuERV-L and IAP in preimplantation mouse embryos</article-title>. <source>Dev Biol</source>, <year>2004</year>. <volume>269</volume>(<issue>1</issue>): p. <fpage>276</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peaston</surname>, <given-names>A.E.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos</article-title>. <source>Dev Cell</source>, <year>2004</year>. <volume>7</volume>(<issue>4</issue>): p. <fpage>597</fpage>–<lpage>606</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sakashita</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Transcription of MERVL retrotransposons is required for preimplantation embryo development</article-title>. <source>Nat Genet</source>, <year>2023</year>. <volume>55</volume>(<issue>3</issue>): p. <fpage>484</fpage>–<lpage>495</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Cook</surname></string-name>, and <string-name><given-names>Z.</given-names> <surname>Chen</surname></string-name></person-group>, <article-title>Systematic evaluation of retroviral LTRs as cis-regulatory elements in mouse embryos</article-title>. <source>Cell Rep</source>, <year>2024</year>. <volume>43</volume>(<issue>3</issue>): p. <fpage>113775</fpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Percharde</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity</article-title>. <source>Cell</source>, <year>2018</year>. <volume>174</volume>(<issue>2</issue>): p. <fpage>391</fpage>–<lpage>405.</lpage> </mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vega-Sendino</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>The homeobox transcription factor DUXBL controls exit from totipotency</article-title>. <source>Nat Genet</source>, <year>2024</year>. <volume>56</volume>(<issue>4</issue>): p. <fpage>697</fpage>–<lpage>709</lpage>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Reprogramming of H3K9me3-dependent heterochromatin during mammalian embryo development</article-title>. <source>Nat Cell Biol</source>, <year>2018</year>. <volume>20</volume>(<issue>5</issue>): p. <fpage>620</fpage>–<lpage>631</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karimi</surname>, <given-names>M.M.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs</article-title>. <source>Cell Stem Cell</source>, <year>2011</year>. <volume>8</volume>(<issue>6</issue>): p. <fpage>676</fpage>–<lpage>87</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leung</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1</article-title>. <source>Proc Natl Acad Sci U S A</source>, <year>2014</year>. <volume>111</volume>(<issue>18</issue>): p. <fpage>6690</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsui</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET</article-title>. <source>Nature</source>, <year>2010</year>. <volume>464</volume>(<issue>7290</issue>): p. <fpage>927</fpage>–<lpage>31</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maksakova</surname>, <given-names>I.A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Distinct roles of KAP1, HP1 and G9a/GLP in silencing of the two-cell-specific retrotransposon MERVL in mouse ES cells</article-title>. <source>Epigenetics Chromatin</source>, <year>2013</year>. <volume>6</volume>(<issue>1</issue>): p. <fpage>15</fpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>SETDB1-Mediated Cell Fate Transition between 2C-Like and Pluripotent States</article-title>. <source>Cell Rep</source>, <year>2020</year>. <volume>30</volume>(<issue>1</issue>): p. <fpage>25</fpage>–<lpage>36.</lpage> </mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname>, <given-names>T.B.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation</article-title>. <source>Proc Natl Acad Sci U S A</source>, <year>2019</year>. <volume>116</volume>(<issue>22</issue>): p. <fpage>10834</fpage>–<lpage>10841</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eckersley-Maslin</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program</article-title>. <source>Genes Dev</source>, <year>2019</year>. <volume>33</volume>(<issue>3-4</issue>): p. <fpage>194</fpage>–<lpage>208</lpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname>, <given-names>S.J.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>DBTMEE: a database of transcriptome in mouse early embryos</article-title>. <source>Nucleic Acids Res</source>, <year>2015</year>. <volume>43</volume>(<issue>Database issue</issue>): p. <fpage>D771</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Modzelewski</surname>, <given-names>A.J.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>A mouse-specific retrotransposon drives a conserved Cdk2ap1 isoform essential for development</article-title>. <source>Cell</source>, <year>2021</year>. <volume>184</volume>(<issue>22</issue>): p. <fpage>5541</fpage>–<lpage>5558.</lpage> </mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>High-efficient FLPo deleter mice in C57BL/6J background</article-title>. <source>PLoS One</source>, <year>2009</year>. <volume>4</volume>(<issue>11</issue>): p. <fpage>e8054</fpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Vries</surname>, <given-names>W.N.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes</article-title>. <source>Genesis</source>, <year>2000</year>. <volume>26</volume>(<issue>2</issue>): p. <fpage>110</fpage>–<lpage>2</lpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="software"><person-group person-group-type="author"><string-name><surname>Krueger</surname>, <given-names>F.</given-names></string-name></person-group>, <article-title>TrimGalore</article-title> <source>GitHub</source> <ext-link ext-link-type="uri" xlink:href="https://github.com/FelixKrueger/TrimGalore">https://github.com/FelixKrueger/TrimGalore</ext-link>. <year>no date</year></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin</surname>, <given-names>M</given-names></string-name></person-group>., <article-title>Cutadapt Removes Adapter Sequences from High-Throughput Sequencing Reads</article-title>. <source>EMBnet Journal</source>, <year>2011</year>. <volume>17</volume>(<issue>1</issue>): p. <fpage>10</fpage>–<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>, <year>2013</year>. <volume>29</volume>(<issue>1</issue>): p. <fpage>15</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>A.T.</given-names> <surname>Lun</surname></string-name>, and <string-name><given-names>G.K.</given-names> <surname>Smyth</surname></string-name></person-group>, <article-title>From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline</article-title>. <source>F1000Res</source>, <year>2016</year>. <volume>5</volume>: p. <fpage>1438</fpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCarthy</surname>, <given-names>D.J.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>G.K.</given-names> <surname>Smyth</surname></string-name></person-group>, <article-title>Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation</article-title>. <source>Nucleic Acids Res</source>, <year>2012</year>. <volume>40</volume>(<issue>10</issue>): p. <fpage>4288</fpage>–<lpage>97</lpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robinson</surname>, <given-names>M.D.</given-names></string-name>, <string-name><given-names>D.J.</given-names> <surname>McCarthy</surname></string-name>, and <string-name><given-names>G.K.</given-names> <surname>Smyth</surname></string-name></person-group>, <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>, <year>2010</year>. <volume>26</volume>(<issue>1</issue>): p. <fpage>139</fpage>–<lpage>40</lpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramirez</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>deepTools2: a next generation web server for deep-sequencing data analysis</article-title>. <source>Nucleic Acids Res</source>, <year>2016</year>. <volume>44</volume>(<issue>W1</issue>): p. <fpage>W160</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title>. <source>Innovation</source>, <year>2021</year>. <volume>2</volume>(<issue>3</issue>): p. <fpage>100141</fpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets</article-title>. <source>Bioinformatics</source>, <year>2015</year>. <volume>31</volume>(<issue>22</issue>): p. <fpage>3593</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>, <year>2009</year>. <volume>25</volume>(<issue>16</issue>): p. <fpage>2078</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liao</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>G.K.</given-names> <surname>Smyth</surname></string-name>, and <string-name><given-names>W.</given-names> <surname>Shi</surname></string-name></person-group>, <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source>Bioinformatics</source>, <year>2014</year>. <volume>30</volume>(<issue>7</issue>): p. <fpage>923</fpage>–<lpage>30</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname>, <given-names>M.I.</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Huber</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Anders</surname></string-name></person-group>, <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>, <year>2014</year>. <volume>15</volume>(<issue>12</issue>): p. <fpage>550</fpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kovaka</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Transcriptome assembly from long-read RNA-seq alignments with StringTie2</article-title>. <source>Genome Biol</source>, <year>2019</year>. <volume>20</volume>(<issue>1</issue>): p. <fpage>278</fpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>H.</given-names></string-name> and <string-name><given-names>R.</given-names> <surname>Durbin</surname></string-name></person-group>, <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source>, <year>2009</year>. <volume>25</volume>(<issue>14</issue>): p. <fpage>1754</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gu</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Eils</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Schlesner</surname></string-name></person-group>, <article-title>Complex heatmaps reveal patterns and correlations in multidimensional genomic data</article-title>. <source>Bioinformatics</source>, <year>2016</year>. <volume>32</volume>(<issue>18</issue>): p. <fpage>2847</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Wickham</surname>, <given-names>H</given-names></string-name></person-group>., <source>ggplot2: Elegant Graphics for Data Analysis</source>. <ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link>. <publisher-name>Springer-Verlag</publisher-name> <publisher-loc>New York</publisher-loc>., <year>2016</year>. <bold>ISBN 978-3-319-24277-4</bold>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="web"><person-group person-group-type="author"><string-name><surname>Yan</surname>, <given-names>L.</given-names></string-name></person-group>, <source>Draw Venn Diagram by ‘ggplot2’</source> <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggvenn/ggvenn.pdf">https://cran.r-project.org/web/packages/ggvenn/ggvenn.pdf</ext-link>. Package ‘ggvenn’, <year>2023</year>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xue</surname>, <given-names>Z.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing</article-title>. <source>Nature</source>, <year>2013</year>. <volume>500</volume>(<issue>7464</issue>): p. <fpage>593</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname>, <given-names>Q.</given-names></string-name>, <etal>et al.</etal></person-group>, <article-title>Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells</article-title>. <source>Science</source>, <year>2014</year>. <volume>343</volume>(<issue>6167</issue>): p. <fpage>193</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="dataref1"><mixed-citation publication-type="data" specific-use="generated"><person-group person-group-type="author"><string-name><surname>Szabó</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Zeng</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fu</surname> <given-names>Z</given-names></string-name></person-group> (<year iso-8601-date="2025">2025</year>) <article-title>Single embryo total RNA sequencing to map the effect of maternal SETDB1 on the 2-celll and 8-cell transcriptome</article-title>. <source>NCBI Gene Expression Omnibus</source>. <pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269417">GSE269417</pub-id></mixed-citation></ref>
<ref id="dataref2"><mixed-citation publication-type="data" specific-use="analyzed"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kou</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>S</given-names></string-name></person-group> (<year iso-8601-date="2018">2018</year>) <article-title>Reprogramming of H3K9me3-dependent heterochromatin during mammalian early embryo development [ChIP-seq]</article-title>. <source>NCBI Gene Expression Omnibus</source>. <pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98149">GSE98149</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109248.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Yan</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02v51f717</institution-id><institution>Peking University</institution>
</institution-wrap>
<city>Beijing</city>
<country>China</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents a <bold>valuable</bold> finding on maternal SETDB1 as a key chromatin repressor that shuts down the 2C gene program and enables normal mouse embryonic development. The evidence supporting the claims of the authors is <bold>solid</bold>, although the inclusion of a causality test, a mechanistic understanding of SETDB1 targeting, and phenotypic quantification would have greatly strengthened the study. The work will be of broad interest to biologists working on embryonic development, stem cells and gene regulation.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109248.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>During the earliest stages of mouse development, the zygote and 2-cell (2C) embryo are totipotent, capable of generating all embryonic and extra-embryonic lineages, and they transiently express a distinctive set of &quot;2C-stage&quot; genes, many driven by MERVL long terminal repeat (LTR) promoters. Although activation of these transcripts is a normal feature of totipotency, they must be rapidly silenced as development proceeds to the 4-cell and 8-cell stages; failure to shut down the 2C program results in developmental arrest. This study examines the role of maternal SETDB1, a histone H3K9 methyltransferase, in suppressing the 2C transcriptional network. Using an oocyte-specific conditional knockout that removes maternal Setdb1 while leaving the paternal allele intact, the authors demonstrate that embryos lacking maternal SETDB1 arrest during cleavage, with very few progressing beyond the 8-cell stage and no morphologically normal blastocysts forming. Transcriptomic analyses reveal persistent expression of MERVL-LTR-driven transcripts and other totipotency markers, indicating a failure to terminate the totipotent state. Together, the data demonstrate that maternally deposited SETDB1 is required to silence the MERVL-driven 2C program and enable the transition from totipotency to pluripotency. More broadly, the work identifies maternal SETDB1 as a key chromatin repressor that deposits repressive H3K9 methylation to shut down the transient 2C gene network and to permit normal preimplantation development.</p>
<p>Strengths:</p>
<p>(1) Closes a key knowledge gap.</p>
<p>The study tackles a central open question - how embryos exit the totipotent 2-cell (2C) state - and provides direct in vivo evidence that epigenetic repression is required to terminate the 2C program for development to proceed. By identifying maternal SETDB1 as the responsible factor, the work substantially advances our understanding of the maternal-to-zygotic transition and early lineage specification.</p>
<p>(2) Clean genetics paired with rigorous genomics.</p>
<p>An oocyte-specific Setdb1 knockout cleanly isolates a maternal-effect requirement, ensuring that early phenotypes arise from loss of maternal protein. The resulting cleavage-stage arrest is unambiguous (most embryos stall before or around the 8-cell stage). State-of-the-art single-embryo RNA-seq across stages - well-matched to low-cell-number constraints - captures genome-wide mis-expression, including persistent 2C transcripts in mutants, strongly supporting the conclusions.</p>
<p>(3) Compelling molecular linkage to phenotype.</p>
<p>Transcriptome data show that without maternal SETDB1, embryos fail to repress a suite of 1-cell/2C-specific genes by the 8-cell stage. The tight correlation between continued activation of the MERVL-driven totipotency network and developmental arrest provides a specific molecular explanation for the observed failure to progress.</p>
<p>(4) Mechanistic insight grounded in chromatin biology.</p>
<p>SETDB1, a H3K9 methyltransferase classically linked to heterochromatin and transposon repression, targets MERVL LTRs and MERVL-driven chimeric transcripts in early embryos. Bioinformatic evidence indicates that these loci normally acquire H3K9me3 during the 2C→4C transition. The data articulate a coherent mechanism: maternal SETDB1 deposits repressive H3K9me3 at 2C gene loci to shut down the totipotency network, extending observations from ESC systems to bona fide embryos.</p>
<p>(5) Broad implications for development and stem-cell biology.</p>
<p>By pinpointing a maternal gatekeeper of the totipotent-to-pluripotent transition, the work suggests that some cases of cleavage-stage arrest (e.g., in IVF) may reflect faulty epigenetic silencing of transposon-driven genes. It also informs stem-cell efforts to control totipotent-like states in vitro (e.g., 2C-like cells), linking epigenetic reprogramming, transposable-element regulation, and developmental potency.</p>
<p>Weaknesses:</p>
<p>(1) Causality not directly demonstrated.</p>
<p>The link among loss of SETDB1, persistence of 2C transcripts, and developmental arrest is compelling but remains correlative. No rescue experiments test whether dampening the 2C/MERVL program restores development. Targeted interventions-e.g., knocking down key 2C drivers (such as Dux) or pharmacologically curbing MERVL-linked transcription in maternal Setdb1 mutants-would strengthen the claim that unchecked 2C activity is causal rather than a by-product of other SETDB1 functions.</p>
<p>(2) Limited mechanistic resolution of SETDB1 targeting.</p>
<p>The study establishes a requirement for maternal SETDB1 but does not define how it is recruited to MERVL loci. Given SETDB1's canonical cooperation with TRIM28/KAP1 and KRAB-ZNFs, upstream sequence-specific factors and/or pre-existing chromatin features likely guide targeting. Direct occupancy and mark-placement evidence (e.g., SETDB1/TRIM28 CUT&amp;RUN or ChIP, and H3K9me3 profiling at MERVL LTRs during the 2C→4C window) would convert inferred mechanisms into demonstrated ones.</p>
<p>(3) Narrow scope on MERVL; broader epigenomic consequences underexplored.</p>
<p>Maternal SETDB1 may restrain additional repeat classes or genes beyond the 2C network. A systematic repeatome analysis (LINEs/SINEs/ERV subfamilies) would clarify specificity versus a general loss of heterochromatin control. Moreover, potential effects on imprinting or DNA methylation balance are not examined; perturbations there could also contribute to arrest. Bisulfite-based DNA methylation maps at imprinted loci and allele-specific expression analyses would help rule in/out these mechanisms.</p>
<p>(4) Phenotype quantitation and transcriptomic breadth could be clearer.</p>
<p>The developmental phenotype is described qualitatively (&quot;very few beyond 8-cell&quot;) without precise stage-wise arrest rates or representative morphology. Tabulated counts (2C/4C/8C/blastocyst), images, and statistics would increase clarity. On the RNA-seq side, the narrative emphasizes known 2C markers; reporting novel/unannotated misregulated transcripts, as well as downregulated pathways (e.g., failure to activate normal 8-cell programs, metabolism, or early lineage markers), would present a fuller portrait of the mutant state.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109248.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Zeng et al. report that Setdb1-/- embryos fail to extinguish the 1- and 2-cell embryo transcriptional program and have permanent expression of MERVL transposable elements. The manuscript is technically sound and well performed, but, in my opinion, the results lack conceptual novelty.</p>
<p>(1) The manuscript builds on previous observations that: 1, Setbd1 is necessary for early mouse development, with knockout embryos rarely reaching the 8-cell stage; 2, SETB1 mediates H3K9me3 deposition at transposable elements in mouse ESCs; 3, SETB1silences MERVLs to prevent 2CLC-state acquisition in mouse ESCs. The strength of the current work is the demonstration that this is not due to a general transcriptional collapse; but otherwise, the findings are not surprising. The well-known (several Nature papers of years ago) crosstalk between m6A RNA modification and H3K9me3 in preventing 2CLC generation also partly compromises the novelty of this work.</p>
<p>(2) The conclusions regarding H3K9me3 deposition are inferred based on previously reported datasets, but there is no direct demonstration.</p>
<p>(3) The detection of chimeric transcripts is somewhat unreliable using short-read sequencing.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109248.1.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Tie-Bo</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8999-2952</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Zhen</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Majewski</surname>
<given-names>Mary F</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liao</surname>
<given-names>Ji</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adams</surname>
<given-names>Marie</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szabó</surname>
<given-names>Piroska E</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9314-7009</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>eLife Assessment</bold></p>
<p>This study presents a valuable finding on maternal SETDB1 as a key chromatin repressor that shuts down the 2C gene program and enables normal mouse embryonic development. The evidence supporting the claims of the authors is solid, although the inclusion of a causality test, a mechanistic understanding of SETDB1 targeting, and phenotypic quantification would have greatly strengthened the study. The work will be of broad interest to biologists working on embryonic development, stem cells and gene regulation.</p>
</disp-quote>
<p>Thank you for this positive evaluation of our work. Please find the point-by point responses to the Reviewer’s comments below.</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Summary:</p>
<p>During the earliest stages of mouse development, the zygote and 2-cell (2C) embryo are totipotent, capable of generating all embryonic and extra-embryonic lineages, and they transiently express a distinctive set of &quot;2C-stage&quot; genes, many driven by MERVL long terminal repeat (LTR) promoters. Although activation of these transcripts is a normal feature of totipotency, they must be rapidly silenced as development proceeds to the 4-cell and 8-cell stages; failure to shut down the 2C program results in developmental arrest. This study examines the role of maternal SETDB1, a histone H3K9 methyltransferase, in suppressing the 2C transcriptional network. Using an oocyte-specific conditional knockout that removes maternal Setdb1 while leaving the paternal allele intact, the authors demonstrate that embryos lacking maternal SETDB1 arrest during cleavage, with very few progressing beyond the 8-cell stage and no morphologically normal blastocysts forming. Transcriptomic analyses reveal persistent expression of MERVL-LTR-driven transcripts and other totipotency markers, indicating a failure to terminate the totipotent state. Together, the data demonstrate that maternally deposited SETDB1 is required to silence the MERVL-driven 2C program and enable the transition from totipotency to pluripotency. More broadly, the work identifies maternal SETDB1 as a key chromatin repressor that deposits repressive H3K9 methylation to shut down the transient 2C gene network and to permit normal preimplantation development.</p>
<p>Strengths:</p>
<p>(1) Closes a key knowledge gap.</p>
<p>The study tackles a central open question - how embryos exit the totipotent 2-cell (2C) state - and provides direct in vivo evidence that epigenetic repression is required to terminate the 2C program for development to proceed. By identifying maternal SETDB1 as the responsible factor, the work substantially advances our understanding of the maternal-to-zygotic transition and early lineage specification.</p>
<p>(2) Clean genetics paired with rigorous genomics.</p>
<p>An oocyte-specific Setdb1 knockout cleanly isolates a maternal-effect requirement, ensuring that early phenotypes arise from loss of maternal protein. The resulting cleavage-stage arrest is unambiguous (most embryos stall before or around the 8-cell stage). State-of-the-art single-embryo RNA-seq across stages - well-matched to low-cell-number constraints - captures genome-wide mis-expression, including persistent 2C transcripts in mutants, strongly supporting the conclusions.</p>
<p>(3) Compelling molecular linkage to phenotype.</p>
<p>Transcriptome data show that without maternal SETDB1, embryos fail to repress a suite of 1-cell/2C-specific genes by the 8-cell stage. The tight correlation between continued activation of the MERVL-driven totipotency network and developmental arrest provides a specific molecular explanation for the observed failure to progress.</p>
<p>(4) Mechanistic insight grounded in chromatin biology.</p>
<p>SETDB1, a H3K9 methyltransferase classically linked to heterochromatin and transposon repression, targets MERVL LTRs and MERVL-driven chimeric transcripts in early embryos. Bioinformatic evidence indicates that these loci normally acquire H3K9me3 during the 2C→4C transition. The data articulate a coherent mechanism: maternal SETDB1 deposits repressive H3K9me3 at 2C gene loci to shut down the totipotency network, extending observations from ESC systems to bona fide embryos.</p>
<p>(5) Broad implications for development and stem-cell biology.</p>
<p>By pinpointing a maternal gatekeeper of the totipotent-to-pluripotent transition, the work suggests that some cases of cleavage-stage arrest (e.g., in IVF) may reflect faulty epigenetic silencing of transposon-driven genes. It also informs stem-cell efforts to control totipotent-like states in vitro (e.g., 2C-like cells), linking epigenetic reprogramming, transposable-element regulation, and developmental potency.</p>
</disp-quote>
<p>We thank Reviewer 1 for recognizing the strengths in our work and for the suggestions below.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>(1) Causality not directly demonstrated.</p>
<p>The link among loss of SETDB1, persistence of 2C transcripts, and developmental arrest is compelling but remains correlative. No rescue experiments test whether dampening the 2C/MERVL program restores development. Targeted interventions-e.g., knocking down key 2C drivers (such as Dux) or pharmacologically curbing MERVL-linked transcription in maternal Setdb1 mutants-would strengthen the claim that unchecked 2C activity is causal rather than a by-product of other SETDB1 functions.</p>
</disp-quote>
<p>We agree that rescue experiments might strengthen causality. Those experiments, however, would be extremely challenging technically because the knockdowns would need to be precisely timed to follow (and not prevent) the wave of 2c-specific activation. Knocking down 2c drivers in the zygote, for example, may prevent switching on the totipotency program. In addition, while sustained MERVL expression—such as that induced by forced DUX expression—disrupts totipotency exit and embryo development (1, 2), derepression of transcription is very broad in Setdb1<sup>mat-/+</sup> embryos and knocking down individual 2C drivers may not be sufficient to rescue development or restore the exit from totipotency.</p>
<disp-quote content-type="editor-comment">
<p>(2) Limited mechanistic resolution of SETDB1 targeting.</p>
<p>The study establishes a requirement for maternal SETDB1 but does not define how it is recruited to MERVL loci. Given SETDB1's canonical cooperation with TRIM28/KAP1 and KRAB-ZNFs, upstream sequence-specific factors and/or pre-existing chromatin features likely guide targeting. Direct occupancy and mark-placement evidence (e.g., SETDB1/TRIM28 CUT&amp;RUN or ChIP, and H3K9me3 profiling at MERVL LTRs during the 2C→4C window) would convert inferred mechanisms into demonstrated ones.</p>
</disp-quote>
<p>We do show H3K9me3 patterns at MERVL LTRs during the early2c-late2c-2c-4c-8c-morula window from a published dataset. Please see the genome browser images in Figures 4C, 4D, 4E, 6D, 6E and Figure S6. We agree that mapping of SETDB1/TRIM28 to those locations would strengthen the mechanistic insight. However, ChIPseq or CUT&amp;RUN of those proteins in preimplantation embryos are not technically feasible. We do provide genetic evidence for the collaboration between SETDB1 and DUXBL, a DNA-binding factor, by showing that DUXBL cannot switch off its top targets without SETDB1 (Figure 6). Future studies will characterize the molecular mechanisms underlying this (likely indirect) collaboration. We do not think that DUXBL and SETDB1 directly interact, because such interaction was not detected by DUXBL IP-MS (3).</p>
<disp-quote content-type="editor-comment">
<p>(3) Narrow scope on MERVL; broader epigenomic consequences underexplored.</p>
<p>Maternal SETDB1 may restrain additional repeat classes or genes beyond the 2C network. A systematic repeatome analysis (LINEs/SINEs/ERV subfamilies) would clarify specificity versus a general loss of heterochromatin control. Moreover, potential effects on imprinting or DNA methylation balance are not examined; perturbations there could also contribute to arrest. Bisulfite-based DNA methylation maps at imprinted loci and allele-specific expression analyses would help rule in/out these mechanisms.</p>
</disp-quote>
<p>We did examine genes and repeat elements beyond the 2c network. We evaluated gene and TE expression changes using four-way comparisons. Please find the results regarding gene expression in Figure 1C-J, Figure S2, Figure S3, Figure S4., Table S2, Table S3, and Table S4. Please find results on TE expression in Figure S5. Table S6, Table S7, and Table S8 and in the text. We agree that DNA methylation may be altered in Setdb1<sup>mat-/+</sup> embryos. In our hands, evaluating this possibility using bisulfite sequencing requires a larger number of embryos than what we can feasibly obtain (the number of obtained mutant embryos is very small). Regarding imprinted gene expression, one cannot fully assess and interpret imprinted gene expression in preimplantation stage embryos before the maternally deposited transcripts are gone. We reported earlier that clear somatic parental-specific patterns of imprinted gene expression may only start later in development, around 8.5 dpc (4).</p>
<disp-quote content-type="editor-comment">
<p>(4) Phenotype quantitation and transcriptomic breadth could be clearer.</p>
<p>The developmental phenotype is described qualitatively (&quot;very few beyond 8-cell&quot;) without precise stage-wise arrest rates or representative morphology. Tabulated counts (2C/4C/8C/blastocyst), images, and statistics would increase clarity. On the RNA-seq side, the narrative emphasizes known 2C markers; reporting novel/unannotated misregulated transcripts, as well as downregulated pathways (e.g., failure to activate normal 8-cell programs, metabolism, or early lineage markers), would present a fuller portrait of the mutant state.</p>
</disp-quote>
<p>Tabulated counts are displayed in Figure 1A, and morphology is shown in Figure S1A. We do say that 4% Setdb1<sup>mat-/+</sup> embryos reached the 8-cel stage by 2.5 dpc. We recovered zero Setdb1<sup>mat-/+</sup> blastocysts at 4.5 dpc (not shown). On the RNA-seq side we do report a more global assessment of transcription of genes and TEs (please see above at point 3), including novel chimeric transcripts (Table S6). Developmental pathways are shown in Figure S3 and Figure S4. Metabolic pathways are displayed in Figure S2.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Zeng et al. report that Setdb1-/- embryos fail to extinguish the 1- and 2-cell embryo transcriptional program and have permanent expression of MERVL transposable elements. The manuscript is technically sound and well performed, but, in my opinion, the results lack conceptual novelty.</p>
<p>(1) The manuscript builds on previous observations that: 1, Setbd1 is necessary for early mouse development, with knockout embryos rarely reaching the 8-cell stage; 2, SETB1 mediates H3K9me3 deposition at transposable elements in mouse ESCs; 3, SETB1silences MERVLs to prevent 2CLC-state acquisition in mouse ESCs. The strength of the current work is the demonstration that this is not due to a general transcriptional collapse; but otherwise, the findings are not surprising. The well-known (several Nature papers of years ago) crosstalk between m6A RNA modification and H3K9me3 in preventing 2CLC generation also partly compromises the novelty of this work.</p>
</disp-quote>
<p>We thank the Reviewer for appreciating the technical quality of our work. Regarding novelty, please consider that prior work in ES cells included contradictory findings (please see our Introduction). Prior embryology work (please see our Introduction) did not explain the preimplantation-stage phenotype. We highly appreciate those earlier works. Our work here answers the expectations drawn from prior studies and unequivocally shows that SETDB1 carries out the developmentally essential function of suppressing MERVLs and the 2-cell program in the mouse embryo.</p>
<disp-quote content-type="editor-comment">
<p>(2) The conclusions regarding H3K9me3 deposition are inferred based on previously reported datasets, but there is no direct demonstration.</p>
</disp-quote>
<p>Dynamic H3K9me3 deposition is displayed at MERVL LTRs during the early2c-late2c-2c-4c-8c-morula window (Figures 4C, 4D, 4E, 6D, 6E and Figure S6) from a published work that has very high-quality data. We agree that demonstrating loss off H3K9me3 in Setdb1<sup>mat-/+</sup> embryos would confirm that the H3K9me3 histone methyltransferase function of SETDB1 (as opposed to any, yet unidentified, non-HMT specific activity of SETDB1) is responsible for shutting down MERVL LTRs. However, ChIP-seq, CUT&amp;RUN, or similar assays are not feasible due to the rarity of Setdb1<sup>mat-/+</sup> embryos.</p>
<disp-quote content-type="editor-comment">
<p>(3) The detection of chimeric transcripts is somewhat unreliable using short-read sequencing.</p>
</disp-quote>
<p>We used single embryo total RNA-seq and we report detecting chimeric transcripts (Table S6), which is considered more reliable than mRNA-seq for detecting chimeric transcripts, because many are not polyadenylated. We acknowledge, however, that long-read sequencing, which recently is becoming available, but which is still very expensive, is currently the most powerful method for detecting chimeric transcripts. This, however, does not affect the major conclusions or the significance of our work.</p>
</body>
</sub-article>
</article>